Call Options

20 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.57 - $23.23 $1.07 Million - $1.34 Million
-57,800 Reduced 72.07%
22,400 $437,000
Q2 2024

Aug 15, 2024

SELL
$17.53 - $22.98 $371,636 - $487,176
-21,200 Reduced 20.91%
80,200 $1.65 Million
Q1 2024

May 07, 2024

BUY
$13.42 - $23.53 $1.36 Million - $2.39 Million
101,400 New
101,400 $2.16 Million
Q2 2023

Aug 11, 2023

BUY
$9.62 - $13.99 $101,971 - $148,294
10,600 Added 89.83%
22,400 $236,000
Q1 2023

May 16, 2023

SELL
$10.71 - $14.6 $123,165 - $167,900
-11,500 Reduced 49.36%
11,800 $144,000
Q4 2022

Feb 14, 2023

SELL
$11.23 - $16.9 $1.19 Million - $1.79 Million
-106,000 Reduced 81.98%
23,300 $289,000
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $862,318 - $1.4 Million
71,800 Added 124.87%
129,300 $1.77 Million
Q2 2022

Aug 15, 2022

SELL
$10.71 - $18.33 $78,183 - $133,809
-7,300 Reduced 11.27%
57,500 $1.05 Million
Q1 2022

May 16, 2022

SELL
$11.78 - $16.98 $432,326 - $623,166
-36,700 Reduced 36.16%
64,800 $1.04 Million
Q4 2021

Feb 14, 2022

SELL
$12.22 - $19.57 $366,600 - $587,100
-30,000 Reduced 22.81%
101,500 $1.42 Million
Q2 2021

Aug 11, 2021

SELL
$20.85 - $29.88 $2.88 Million - $4.12 Million
-138,000 Reduced 51.21%
131,500 $2.74 Million
Q1 2021

May 17, 2021

BUY
$24.75 - $39.14 $4.29 Million - $6.78 Million
173,300 Added 180.15%
269,500 $7.62 Million
Q4 2020

Feb 16, 2021

BUY
$29.0 - $41.62 $1.48 Million - $2.13 Million
51,200 Added 113.78%
96,200 $3.14 Million
Q3 2020

Nov 16, 2020

BUY
$16.3 - $30.64 $405,870 - $762,936
24,900 Added 123.88%
45,000 $1.38 Million
Q2 2020

Aug 14, 2020

BUY
$7.95 - $18.81 $57,240 - $135,432
7,200 Added 55.81%
20,100 $328,000
Q4 2019

Feb 14, 2020

SELL
$12.97 - $15.94 $259,400 - $318,800
-20,000 Reduced 60.79%
12,900 $177,000
Q1 2019

May 15, 2019

BUY
$13.73 - $16.87 $451,717 - $555,023
32,900 New
32,900 $546,000
Q4 2018

Feb 14, 2019

SELL
$10.6 - $17.49 $142,040 - $234,365
-13,400 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$16.65 - $21.85 $53,279 - $69,920
3,200 Added 31.37%
13,400 $235,000
Q2 2018

Aug 14, 2018

BUY
$14.8 - $18.8 $150,960 - $191,760
10,200 New
10,200 $186,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $1.06B
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.